| Application no. and date | 99972101.2 (espacenet) (Federated) (European Patent Register), 19991109 | | Patent/reg. no. and date | DK/EP 1128829, 20050511 | | Publication date | 20010905 | | Priority no. and date | FR 9814250, 19981113 | | EP pub. no. and date |
EP 1128829 20010905 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | | | Inventor | DIB, Michel, 11, rue Henri Michaux
F-75013 Paris, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/425 (2006.01) , A61K 31/355 (2006.01) , A61K 31/425 (2006.01) , A61K 31/425 (2006.01) , A61P 25/28 (2006.01) | | Title | Kombination af riluzol og alfa-tocopherol | | Int. application no. | FR1999002753 | | Int. publication no. | WO2000028992 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
